Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Sep 17;13(18):e033807.
doi: 10.1161/JAHA.123.033807. Epub 2024 Sep 6.

Poststroke Cognitive Impairment and the Risk of Recurrent Stroke and Mortality: Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Poststroke Cognitive Impairment and the Risk of Recurrent Stroke and Mortality: Systematic Review and Meta-Analysis

N Maritza Dowling et al. J Am Heart Assoc. .

Abstract

Background: Poststroke cognitive impairment (PSCI) occurs in about 60% of patients with stroke in the first year after stroke. However, the question regarding risks of recurrent stroke and mortality in patients with PSCI remains controversial. The goal of this study was to conduct a meta-analysis of published literature to estimate the risks of stroke recurrence and mortality associated with PSCI.

Methods and results: Electronic databases were screened for eligible studies published from 1990 to 2023. The primary end points of this study were recurrent stroke and mortality. Pooled estimates were calculated as hazard ratios (HR) with 95% CIs. Meta-regression analyses evaluated moderating effects of PSCI severity, study design, and study period on recurrent stroke and mortality. Pooled data from 27 studies comprised 39 412 patients with ischemic stroke. Nine studies evaluated the association between PSCI and risk of stroke recurrence that showed the hazard of recurrent stroke risk was significantly higher in patients with PSCI compared with those without it (HR, 1.59 [95% CI, 1.29-1.94]; I2=52.2%). Eighteen studies examined the impact of PSCI on mortality risk. The pooled hazard of mortality was significantly higher in the group with PSCI relative to the non-PSCI group (HR, 2.07 [95% CI, 1.65 -2.59]; I2=89.3%). Meta-regressions showed that the average effect of PSCI on mortality risk differed across study period and study design.

Conclusions: Based on this meta-analysis PSCI was statistically significantly associated with increased risks of recurrent stroke and all-cause mortality. Poststroke neurocognitive assessment may identify patients at a higher risk who may require more aggressive interventions for secondary prevention.

Keywords: dementia; mortality risk; poststroke cognitive impairment; stroke recurrence.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta‐Analysis.
PSCI indicates poststroke cognitive impairment.
Figure 2
Figure 2. Forest plots for observed hazard ratios of recurrent stroke (pooled analyses).
The plot shows a log transformed x axis. df indicates degrees of freedom; I 2, percentage of variation across studies due to heterogeneity rather than chance; Q, Cochran's Q measure of heterogeneity; RE, random effects model; and τ2, estimated amount of total heterogeneity. (Pooled hazard ratio estimate for the fixed effects model was 1.37 [95% CI, 1.22–1.55]; Q=18.51, df=8, P=0.02; I2=56%).
Figure 3
Figure 3. Forest plot of the observed hazard ratios of mortality (pooled analyses).
The plot shows a log transformed x axis. df indicates degrees of freedom; I 2, percentage of variation across studies due to heterogeneity rather than chance; τ2, estimated amount of total heterogeneity; Q, Cochran's Q measure of heterogeneity; and RE, random effects model. (Pooled hazard ratio estimate for the fixed effects model was 1.47 [95% CI, 1.40–1.54]; Q=82.16, df=17, P<0.001; I 2=79.3%).

References

    1. Mijajlović MD, Pavlović A, Brainin M, Heiss WD, Quinn TJ, Ihle‐Hansen HB, Hermann DM, Assayag EB, Richard E, Thiel A, et al. Post‐stroke dementia—a comprehensive review. BMC Med. 2017;15:1–12. doi: 10.1186/s12916-017-0779-7 - DOI - PMC - PubMed
    1. El Husseini N, Katzan IL, Rost NS, Blake ML, Byun E, Pendlebury ST, Aparicio HJ, Marquine MJ, Gottesman RF, Smith EE, et al. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2023;54:272–291. doi: 10.1161/STR.0000000000000430 - DOI - PubMed
    1. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Pirro M, Hanzawa LK. Dementia after stroke is a predictor of long‐term survival. Stroke. 1994;25:1915–1919. doi: 10.1161/01.STR.25.10.1915 - DOI - PubMed
    1. Moroney JT, Bagiella E, Tatemichi TK, Paik MC, Stern Y, Desmond DW. Dementia after stroke increases the risk of long‐term stroke recurrence. Neurology. 1997;48:1317–1325. doi: 10.1212/WNL.48.5.1317 - DOI - PubMed
    1. Hénon H, Durieu I, Lebert F, Pasquier F, Leys D. Influence of prestroke dementia on early and delayed mortality in stroke patients. J Neurol. 2003;250:10–16. doi: 10.1007/s00415-003-0917-3 - DOI - PubMed

LinkOut - more resources